S. Cepa

Synthesis of specific polychlorinated dibenzo-p-dioxins.

A. Gray, O. Aniline, S. Cepa, 1976, The Journal of organic chemistry.

Intervention of the smiles rearrangement in syntheses of dibenzo-p-dioxins. 1,2,3,6,7,8- and 1,2,3,7,8,9-hexachlorodibenzo-p-dioxin (hcdd)

J. Cantrell, A. Gray, S. Cepa, 1975 .

The in vitro hepatic metabolism of ABT-418, a cholinergic channel activator, in rats, dogs, cynomolgus monkeys, and humans.

A. D. Rodrigues, J. Sullivan, D. Garvey, 1994, Drug metabolism and disposition: the biological fate of chemicals.

Liquid chromatography combined with tandem mass spectrometry for the confirmation of sarafloxacin in catfish tissue.

S. Cepa, S. Menacherry, J. Schilling, 1996, Analytical chemistry.

Discovery of potent, selective, orally bioavailable stearoyl-CoA desaturase 1 inhibitors.

Bo Liu, Gang Liu, Hongyu Zhao, 2007, Journal of medicinal chemistry.

Individual serum bile acid profiling in rats aids in human risk assessment of drug‐induced liver injury due to BSEP inhibition

Y. Ran, L. Salphati, J. Tarrant, 2018, Toxicology and applied pharmacology.

Novel Modes of Inhibition of Wild-Type Isocitrate Dehydrogenase 1 (IDH1): Direct Covalent Modification of His315.

A. Vasudevan, Chaohong Sun, C. Jakob, 2018, Journal of medicinal chemistry.

Direct analysis and identification of Helicobacter and Campylobacter species by MALDI-TOF mass spectrometry.

J. Uher, M. A. Winkler, S. Cepa, 1999, Analytical chemistry.

Glucuronidation of zileuton (A-64077) by human hepatic microsomes.

J. Bouska, D. Sweeny, H. Nellans, 1992, Drug metabolism and disposition: the biological fate of chemicals.